X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2231) 2231
humans (2187) 2187
bortezomib (1401) 1401
male (1311) 1311
female (1156) 1156
pyrazines - therapeutic use (1112) 1112
middle aged (1069) 1069
pyrazines - adverse effects (1065) 1065
pyrazines - administration & dosage (917) 917
aged (904) 904
multiple myeloma - drug therapy (769) 769
adult (736) 736
oncology (707) 707
boronic acids - adverse effects (673) 673
boronic acids - administration & dosage (662) 662
boronic acids - therapeutic use (619) 619
treatment outcome (594) 594
hematology (525) 525
multiple myeloma (511) 511
pyrazines - pharmacology (479) 479
antineoplastic combined chemotherapy protocols - therapeutic use (470) 470
animals (451) 451
antineoplastic agents - therapeutic use (433) 433
sitagliptin phosphate (401) 401
antineoplastic agents - adverse effects (400) 400
diabetes mellitus, type 2 - drug therapy (340) 340
antineoplastic combined chemotherapy protocols - adverse effects (294) 294
therapy (291) 291
aged, 80 and over (290) 290
pharmacology & pharmacy (288) 288
care and treatment (285) 285
triazoles - therapeutic use (265) 265
cancer (251) 251
dexamethasone - administration & dosage (238) 238
dexamethasone (231) 231
drug therapy, combination (229) 229
hypoglycemic agents - therapeutic use (229) 229
dose-response relationship, drug (227) 227
thalidomide (214) 214
research (211) 211
chemotherapy (210) 210
thalidomide - analogs & derivatives (209) 209
drug therapy (208) 208
boronic acids - pharmacology (201) 201
abridged index medicus (200) 200
antineoplastic agents - administration & dosage (200) 200
triazoles - adverse effects (198) 198
mice (196) 196
stem-cell transplantation (195) 195
thalidomide - administration & dosage (188) 188
medicine & public health (185) 185
endocrinology & metabolism (183) 183
multiple-myeloma (183) 183
drug administration schedule (180) 180
sitagliptin (179) 179
clinical trials as topic (176) 176
type 2 diabetes (176) 176
recurrence (175) 175
apoptosis (170) 170
protease inhibitors - therapeutic use (170) 170
trial (166) 166
proteasome inhibitors (165) 165
hypoglycemic agents - adverse effects (161) 161
analysis (154) 154
hematology, oncology and palliative medicine (154) 154
multiple myeloma - pathology (153) 153
thalidomide - therapeutic use (151) 151
dosage and administration (148) 148
diabetes (146) 146
transplantation (146) 146
rats (140) 140
proteasome inhibitor bortezomib (138) 138
retrospective studies (138) 138
disease-free survival (136) 136
pyrazines - pharmacokinetics (136) 136
dipeptidyl-peptidase iv inhibitors - therapeutic use (135) 135
clinical trials (134) 134
antineoplastic agents - pharmacology (132) 132
article (130) 130
lenalidomide (128) 128
multiple myeloma - mortality (128) 128
multiple myeloma - therapy (127) 127
survival (127) 127
double-blind method (126) 126
triazoles - administration & dosage (126) 126
medicine, general & internal (125) 125
time factors (125) 125
combination (124) 124
efficacy (123) 123
double-blind (122) 122
risk factors (121) 121
follow-up studies (120) 120
prognosis (119) 119
multiple myeloma - complications (117) 117
peripheral neuropathy (117) 117
protease inhibitors - adverse effects (116) 116
thalidomide - adverse effects (115) 115
antineoplastic combined chemotherapy protocols - administration & dosage (114) 114
dipeptidyl peptidase-4 inhibitor (114) 114
hypoglycemic agents - administration & dosage (114) 114
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2276) 2276
Japanese (41) 41
Chinese (31) 31
German (26) 26
French (20) 20
Italian (11) 11
Spanish (11) 11
Swedish (6) 6
Russian (5) 5
Polish (4) 4
Czech (3) 3
Danish (3) 3
Hebrew (2) 2
Norwegian (2) 2
Dutch (1) 1
Finnish (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2005, Volume 129, Issue 6, pp. 755 - 762
Journal Article
Journal Article
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 02/2013, Volume 2, Issue 1, pp. e003277 - n/a
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2013, Volume 160, Issue 5, pp. 649 - 659
Multiple myeloma ( MM ) typically follows a relapsing course with many patients requiring multiple therapies. This single‐arm phase 2 study prospectively... 
relapsed | multiple myeloma | phase 2 | bortezomib | retreatment | Retreatment | Phase 2 | Bortezomib | Relapsed | Multiple myeloma | PEGYLATED LIPOSOMAL DOXORUBICIN | FOLLOW-UP | THALIDOMIDE | INDUCTION | COMBINATION | TRIAL | THERAPY | PLUS DEXAMETHASONE | PERIPHERAL NEUROPATHY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Recurrence | Peripheral Nervous System Diseases - chemically induced | Prospective Studies | Humans | Middle Aged | Pyrazines - administration & dosage | Salvage Therapy | Boronic Acids - adverse effects | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Multiple Myeloma - drug therapy | Antineoplastic Agents - adverse effects | Aged, 80 and over | Protease Inhibitors - administration & dosage | Protease Inhibitors - adverse effects | Adult | Female | Boronic Acids - administration & dosage | Protease Inhibitors - therapeutic use | Multiple Myeloma - surgery | Dexamethasone - administration & dosage | Europe | Kaplan-Meier Estimate | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Combined Modality Therapy | Thrombocytopenia - chemically induced | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Aged | Thalidomide - therapeutic use | Gastrointestinal Diseases - chemically induced | Complications and side effects | Medical research | Care and treatment | Relapse | Dexamethasone | Medicine, Experimental | Diseases | Index Medicus | Thrombocytopenia | Neuropathy | Toxicity
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 10, pp. 944 - 953
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2011, Volume 153, Issue 6, pp. 729 - 740
Journal Article